NTRA
Natera Inc
NASDAQ: NTRA · HEALTHCARE · DIAGNOSTICS & RESEARCH
$194.75
-2.71% today
Updated 2026-04-29
Market cap
$27.81B
P/E ratio
—
P/S ratio
12.06x
EPS (TTM)
$-1.52
Dividend yield
—
52W range
$132 – $256
Volume
1.3M
Natera Inc (NTRA) Insider transactions
Net insider activity
Net selling (203,612 shares)
Buy transactions
20
Sell transactions
80
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2029-06-23 | BROPHY, MICHAEL BURKES | Chief Financial Officer | Sale | 12,500 | — | — |
| 2029-06-08 | BROPHY, MICHAEL BURKES | Chief Financial Officer | Sale | 25,000 | — | — |
| 2026-04-17 | SHEENA, JONATHAN | Director, CO-FOUNDER | Sale | 750 | $199.59 | $149692.95 |
| 2026-04-06 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 58,292 | — | — |
| 2026-04-06 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Buy | 58,292 | $9.59 | $559020.28 |
| 2026-04-06 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 27,610 | $204.87 | $5.66M |
| 2026-04-01 | RABINOWITZ, DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sale | 3,213 | $203.07 | $652470.34 |
| 2026-04-01 | RABINOWITZ, DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sale | 1,909 | $205.00 | $391349.96 |
| 2026-04-01 | RABINOWITZ, DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sale | 1,778 | $202.01 | $359167.02 |
| 2026-04-01 | RABINOWITZ, DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sale | 1,200 | $203.83 | $244590.96 |
| 2026-04-01 | RABINOWITZ, DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sale | 300 | $200.79 | $60236.04 |
| 2026-04-01 | MOSHKEVICH, SOLOMON | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 1,048 | $201.32 | $210983.99 |
| 2026-04-01 | MOSHKEVICH, SOLOMON | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 1,000 | $202.36 | $202363.80 |
| 2026-04-01 | MOSHKEVICH, SOLOMON | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 952 | $203.31 | $193551.69 |
| 2026-03-31 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 41,708 | — | — |
| 2026-03-31 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Buy | 41,708 | $9.59 | $399979.72 |
| 2026-03-20 | SHEENA, JONATHAN | Director, CO-FOUNDER | Sale | 371 | $200.97 | $74561.35 |
| 2026-03-20 | SHEENA, JONATHAN | Director, CO-FOUNDER | Sale | 280 | $200.90 | $56252.64 |
| 2026-03-20 | SHEENA, JONATHAN | Director, CO-FOUNDER | Sale | 239 | $198.85 | $47526.32 |
| 2026-03-20 | SHEENA, JONATHAN | Director, CO-FOUNDER | Sale | 235 | $198.49 | $46644.19 |
| 2026-03-20 | SHEENA, JONATHAN | Director, CO-FOUNDER | Sale | 140 | $199.82 | $27975.40 |
| 2026-03-18 | SHEENA, JONATHAN | Director, CO-FOUNDER | Sale | 1,814 | $198.65 | $360355.09 |
| 2026-03-18 | SHEENA, JONATHAN | Director, CO-FOUNDER | Sale | 956 | $197.84 | $189135.14 |
| 2026-03-18 | SHEENA, JONATHAN | Director, CO-FOUNDER | Sale | 300 | $196.27 | $58880.01 |
| 2026-03-16 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 50,000 | — | — |
| 2026-03-16 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Buy | 50,000 | $9.59 | $479500.00 |
| 2026-03-16 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 24,814 | $196.23 | $4.87M |
| 2026-03-16 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 16,457 | $197.22 | $3.25M |
| 2026-03-16 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 4,875 | $195.42 | $952695.90 |
| 2026-03-16 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 2,300 | $194.17 | $446592.61 |
| 2026-03-16 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 900 | $192.43 | $173185.02 |
| 2026-03-16 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 300 | $190.68 | $57203.07 |
| 2026-03-16 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 254 | $198.02 | $50297.18 |
| 2026-03-16 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 100 | $190.07 | $19007.08 |
| 2026-03-13 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 75,000 | — | — |
| 2026-03-13 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Buy | 75,000 | $9.59 | $719250.00 |
| 2026-03-13 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 21,504 | $189.50 | $4.08M |
| 2026-03-13 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 21,476 | $188.54 | $4.05M |
| 2026-03-13 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 17,037 | $187.63 | $3.20M |
| 2026-03-13 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 13,883 | $190.46 | $2.64M |
| 2026-03-13 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 1,100 | $191.22 | $210344.97 |
| 2026-03-13 | CHAPMAN, ROWAN E | Director | Sale | 122 | $191.38 | $23348.36 |
| 2026-03-12 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 75,000 | — | — |
| 2026-03-12 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Buy | 75,000 | $9.59 | $719250.00 |
| 2026-03-12 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 22,063 | $190.53 | $4.20M |
| 2026-03-12 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 9,896 | $191.55 | $1.90M |
| 2026-03-12 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 8,579 | $192.79 | $1.65M |
| 2026-03-12 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 8,091 | $186.75 | $1.51M |
| 2026-03-12 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 7,043 | $193.58 | $1.36M |
| 2026-03-12 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 6,451 | $188.52 | $1.22M |
| 2026-03-12 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 5,809 | $187.52 | $1.09M |
| 2026-03-12 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 4,082 | $194.57 | $794218.00 |
| 2026-03-12 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 2,886 | $189.64 | $547306.81 |
| 2026-03-12 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Sale | 100 | $195.32 | $19532.00 |
| 2026-03-10 | SHEENA, JONATHAN | Director, CO-FOUNDER | Sale | 127 | $204.13 | $25924.85 |
| 2026-03-10 | RABINOWITZ, DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sale | 1,745 | $204.13 | $356211.56 |
| 2026-03-10 | MOSHKEVICH, SOLOMON | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 915 | $204.13 | $186781.42 |
| 2026-03-10 | FESKO, JOHN | PRESIDENT, CHIEF BUS. OFFICER | Sale | 707 | $204.13 | $144321.82 |
| 2026-03-10 | CHAPMAN, STEVEN LEONARD | Director, CEO AND PRESIDENT | Sale | 5,623 | $204.13 | $1.15M |
| 2026-03-10 | BROPHY, MICHAEL BURKES | CHIEF FINANCIAL OFFICER | Sale | 785 | $204.13 | $160244.17 |
| 2026-03-09 | SHEENA, JONATHAN | Director, CO-FOUNDER | Buy | 258 | — | — |
| 2026-03-09 | RABINOWITZ, DANIEL | SEC. AND CHIEF LEGAL OFFICER | Buy | 1,745 | — | — |
| 2026-03-09 | MOSHKEVICH, SOLOMON | PRESIDENT, CLINICALDIAGNOSTICS | Buy | 1,774 | — | — |
| 2026-03-09 | FESKO, JOHN | PRESIDENT, CHIEF BUS. OFFICER | Buy | 1,774 | — | — |
| 2026-03-09 | CHAPMAN, STEVEN LEONARD | Director, CEO AND PRESIDENT | Buy | 5,623 | — | — |
| 2026-03-09 | BROPHY, MICHAEL BURKES | CHIEF FINANCIAL OFFICER | Buy | 1,968 | — | — |
| 2026-03-06 | RABINOWITZ, DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sale | 5,598 | — | — |
| 2026-03-06 | RABINOWITZ, DANIEL | SEC. AND CHIEF LEGAL OFFICER | Buy | 5,598 | $19.68 | $110168.64 |
| 2026-03-06 | RABINOWITZ, DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sale | 2,900 | $194.77 | $564832.42 |
| 2026-03-06 | RABINOWITZ, DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sale | 1,998 | $198.04 | $395693.51 |
| 2026-03-06 | RABINOWITZ, DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sale | 1,600 | $195.80 | $313272.64 |
| 2026-03-06 | RABINOWITZ, DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sale | 1,500 | $196.94 | $295406.10 |
| 2026-03-06 | RABINOWITZ, DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sale | 400 | $193.73 | $77491.16 |
| 2026-03-02 | SHEENA, JONATHAN | Director, CO-FOUNDER | Sale | 2,400 | $200.42 | $481012.08 |
| 2026-03-02 | SHEENA, JONATHAN | Director, CO-FOUNDER | Sale | 470 | $198.50 | $93292.93 |
| 2026-03-02 | SHEENA, JONATHAN | Director, CO-FOUNDER | Sale | 100 | $202.85 | $20285.00 |
| 2026-03-02 | MOSHKEVICH, SOLOMON | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 5,125 | — | — |
| 2026-03-02 | MOSHKEVICH, SOLOMON | PRESIDENT, CLINICALDIAGNOSTICS | Buy | 5,125 | $9.59 | $49148.75 |
| 2026-03-02 | MOSHKEVICH, SOLOMON | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 1,594 | $200.11 | $318971.04 |
| 2026-03-02 | MOSHKEVICH, SOLOMON | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 931 | $198.83 | $185114.27 |
| 2026-03-02 | MOSHKEVICH, SOLOMON | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 475 | $200.97 | $95459.75 |
| 2026-03-02 | CHAPMAN, STEVEN LEONARD | Director, CEO AND PRESIDENT | Sale | 2,463 | $200.24 | $493192.60 |
| 2026-03-02 | CHAPMAN, STEVEN LEONARD | Director, CEO AND PRESIDENT | Sale | 1,122 | $199.17 | $223472.89 |
| 2026-03-02 | CHAPMAN, STEVEN LEONARD | Director, CEO AND PRESIDENT | Sale | 365 | $201.18 | $73429.50 |
| 2026-02-27 | SHEENA, JONATHAN | Director, CO-FOUNDER | Buy | 2,103 | — | — |
| 2026-02-27 | RABINOWITZ, MATTHEW | Director, EXECUTIVE CHAIRMAN | Buy | 29,920 | — | — |
| 2026-02-27 | RABINOWITZ, DANIEL | SEC. AND CHIEF LEGAL OFFICER | Buy | 12,272 | — | — |
| 2026-02-27 | MOSHKEVICH, SOLOMON | PRESIDENT, CLINICALDIAGNOSTICS | Buy | 10,051 | — | — |
| 2026-02-27 | FESKO, JOHN | PRESIDENT, CHIEF BUS. OFFICER | Buy | 10,051 | — | — |
| 2026-02-27 | CHAPMAN, STEVEN LEONARD | Director, CEO AND PRESIDENT | Buy | 37,401 | — | — |
| 2026-02-27 | BROPHY, MICHAEL BURKES | CHIEF FINANCIAL OFFICER | Buy | 10,051 | — | — |
| 2026-02-03 | SHEENA, JONATHAN | Director, CO-FOUNDER | Sale | 435 | $230.77 | $100384.08 |
| 2026-02-03 | RABINOWITZ, DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sale | 1,334 | $230.77 | $307844.51 |
| 2026-02-03 | MOSHKEVICH, SOLOMON | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 1,639 | $230.77 | $378228.75 |
| 2026-02-03 | FESKO, JOHN | PRESIDENT, CHIEF BUS. OFFICER | Sale | 2,415 | $231.14 | $558203.10 |
| 2026-02-03 | FESKO, JOHN | PRESIDENT, CHIEF BUS. OFFICER | Sale | 1,179 | $230.77 | $272075.47 |
| 2026-02-03 | CHAPMAN, STEVEN LEONARD | Director, CEO AND PRESIDENT | Sale | 4,725 | $230.77 | $1.09M |
| 2026-02-03 | BROPHY, MICHAEL BURKES | CHIEF FINANCIAL OFFICER | Sale | 4,971 | $227.45 | $1.13M |
| 2026-02-03 | BROPHY, MICHAEL BURKES | CHIEF FINANCIAL OFFICER | Sale | 1,268 | $230.77 | $292613.82 |
| 2026-02-03 | BROPHY, MICHAEL BURKES | CHIEF FINANCIAL OFFICER | Sale | 700 | $225.25 | $157673.53 |